The Metastasis Research Society and AACR share a common goal of preventing and curing cancer through research. This joint conference will focus on metastasis and the impact of the tumor microenvironment on cancer initiation and progression.

This meeting will explore the promise of this biologically based approach to therapeutic development and clinical investigations, review the current state of accomplishments in these areas, and discuss solutions to some of the challenges as well as the resulting future advancements.

This conference will address all levels of basic, population, clinical, and transdisciplinary research related to cancer. The goals of this conference are to bring together physicians, scientists, health professionals, and health care leaders working in a variety of disciplines to discuss the latest findings in their fields, to foster collaborative interdisciplinary interactions and partnerships, and to stimulate the development of new research in cancer health disparities.

This new workshop will introduce the full spectrum of translational cancer research to late-stage Ph.D. candidates, early-career Ph.D.s, and established Ph.D.s in transition to translational research. The weeklong immersion course will feature: 1) didactic lectures; 2) offsite interactive visits to radiology and pathobiology departments, an IRB session, and outpatient cancer treatment clinics; and 3) small group discussion sessions.

This annual conference promotes public, academic, government, and industry awareness of the vital importance of cancer prevention science in reducing cancer incidence and mortality. It catalyzes coordinated, focused research in basic, clinical, epidemiologic, and behavioral science that promises to accelerate cancer prevention. The theme of this year’s conference is Prevention: From Basic Science to Public Health Benefit.

If you are a family medicine physician, oncologist, geriatrician, neurologist, nephrologist, pediatrician, a pain and palliative physician, nurse, social worker, psychologist, physical therapist, chaplain or any other paramedical professional, interested in improving your palliative care skills and knowledge - DO NOT MISS THIS EVENT!

This Symposium has been organized to reflect the many recent advances in the early development of promising new compounds, which are on different levels of preclinical and clinical development. It will bring together delegates from all over the world igniting a vast exchange of information whilst promoting and developing global partnerships in translational research.

This conference enables practicing oncologists to stay ahead in their field. Distinguished experts present the latest scientific findings and practice changing advances in oncology - selected from a huge volume of literature, clinical and basic research information - and as these relate to clinical practice.

This conference provides a forum to update your knowledge in the field, confirm your current practice, and receive valuable take-home information on exciting new screening and staging modalities, management approaches, and emerging treatment options.

This is the third conference of this tumor immunology series. A hallmark of this conference is that it integrates several subdisciplines and focuses on cancer immunology as a whole. Some of the themes that will be addressed in this year’s conference include: the tumor microenvironment, harnessing immune responses in cancer, and regulating immune responses in cancer.

CELCC has a long and successful history. The main aim of CELCC meetings is to educate oncopulmonologists working in the region and, moreover, offer them an opportunity to present the results of their scientific and clinical work. Therefore, we invite leaders in thoracic oncology to participate and suggest others involved in the field submit abstracts of their proposed presentations. The CELCC was last held in Budapest ten years ago, and its success then and over the past years has encouraged us to organize this event again.

This is the 4th APLCC, "Step Forward to Personalized Medicine; Asian Pacific Perspectives." The lung cancer mortality rate is the highest in Asian-Pacific countries and still increasing. This stands in stark contrast to western countries where the rate has plateaued and shows signs of decreasing. We expect more than 700 delegates from over 20 Asian-Pacific countries and the conference will be a great forum for communicating, exchanging and obtaining cutting-edge knowledge in the field of lung cancer epidemiology, prevention, diagnosis, management and translational research. Many world-renowned experts from Europe, North America as well as the Asian Pacific region will attend this gathering to share their expertise.

The 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology will offer valuable information on the interdisciplinary approach in the treatment of thoracic malignancies. Research shows that a combination of therapies can improve patient outcomes by reducing side effects and improving survival rates.

This unique international conference provides a platform for all pharmaceutical scientists, internists and primary care physicians to discuss and learn about all the important international breakthrough developments on drug discovery and on new therapeutics.

This AACR Special Conference will assemble prominent investigators to discuss recent advances in this rapidly growing area. Sessions will focus on the basic research which is studying the role of PI3K/mTOR and related pathways in cancer.

With nearly 1,000 attendees from 58 countries in attendance at the 2010 congress in Amsterdam, The Netherlands, this meeting has become a “must attend” event for those interested in state-of-the-art lung cancer management. As the field of lung cancer research and treatment is ever-evolving, this comprehensive focus on the multimodal management of lung cancer in Europe is sure to be a rewarding educational experience from all lung cancer-related disciplines.

Better Care through Personalized Medical Approaches

The 14th World Conference on Lung Cancer will be a great opportunity for lung cancer professionals from around the world to share the most up-to-date information regarding the science and advances in the treatment of lung cancer. More than 200 lung cancer specialists from a wide range of disciplines will participate in the scientific programme and their presentations will provide delegates with information on the latest developments in basic science and clinical treatment. A special Young Investigators Day will be held on July 3rd, covering an array of special topics of great interest to young investigators.